Lyme Disease Vaccine Study Opportunity

Care Access is currently working with Pfizer on conducting a Lyme Disease Vaccine Study in the northeastern United States. As you may be aware, Pennsylvania has the highest number of Lyme Disease cases in the United States. This study presents a unique opportunity for the public to help develop a highly effective prevention tool against Lyme Disease.

Care Access is a national healthcare company that breaks down traditional barriers in clinical research and is taking steps to make clinical studies more accessible, representative, and inclusive for people of all backgrounds. We actively partner with physicians, clinics, and hospitals in communities that are traditionally left out of the clinical trial process.

Our Care Access team would like the opportunity to meet with you to discuss the possibility of conducting Lyme Disease educational sessions within your organization or partnering with you to disseminate educational materials on how your patrons can take part in this study.

Go to our website www.LymeTrial.com [lymetrial.com] for more information. I have also included additional links below about this trial being conducted in other parts of the country.

https://vineyardgazette.com/news/2022/07/12/lyme-vaccine-trial-set-begin-next-month-vineyard [vineyardgazette.com]

https://www.mvtimes.com/2022/07/11/lyme-trials-coming-vineyard/ [mvtimes.com]

Please feel free to contact me with any questions regarding the study and who is eligible to participate.

Thank you for your time and consideration. We are looking forward to connecting with you.